Expression of Cdc2 and Cyclin B1 in Helicobacter pylori-Associated Gastric MALT and MALT Lymphoma : Relationship to Cell Death, Proliferation, and Transformation

• Published in: The American journal of pathology Vol. 156; no. 1; pp. 217 - 225
• Main Authors: Banerjee, Sushanta K, Weston, Allan P, Zoubine, Mikhail N, Campbell, Donald R, Cherian, Rachel
• Format: Journal Article
• Language: English
• Published: Bethesda, MD ASIP 01-01-2000; American Society for Investigative Pathology
• Subjects: Apoptosis; Biological and medical sciences; CDC2 Protein Kinase - metabolism; Cell Death; Cell Division; Cell Transformation, Neoplastic; Chronic Disease; Cyclin B - metabolism; Cyclin B1; Gastric Mucosa - metabolism; Gastric Mucosa - pathology; Gastritis - metabolism; Gastroenterology. Liver. Pancreas. Abdomen; Helicobacter Infections - complications; Helicobacter pylori; Hematologic and hematopoietic diseases; Humans; Immunohistochemistry; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymphoid Tissue - metabolism; Lymphoid Tissue - pathology; Lymphoma, B-Cell, Marginal Zone - metabolism; Lymphoma, B-Cell, Marginal Zone - pathology; Medical sciences; Proliferating Cell Nuclear Antigen - metabolism; Reference Values; Regular; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumors; Human; Immunohistochemistry; Cell proliferation; Stomach; Spirillales; Spirillaceae; Cyclin; Malignant hemopathy; Lymphoid tissue; Non Hodgkin lymphoma; Carcinogenesis; Gastritis; Infection; Pathology; MALT lymphoma; Helicobacter pylori; Lymphoproliferative syndrome; Cell cycle; Bacteriosis; Digestive diseases; Bacteria; PCNA antigen; Gastric disease; Apoptosis
• ISSN: 0002-9440; 1525-2191
• DOI: 10.1016/S0002-9440(10)64722-0

Mucosa-associated lymphoid tissue (MALT) may accumulate within gastric mucosa as a result of long standing Helicobacter pylori infection, and this acquired MALT may eventually develop into low-grade B-cell MALT lymphoma. To determine the possible association of cell cycle regulatory proteins and apoptotic cell death in the transformation of H. pylori gastritis to MALT lymphoma, the extent of cell proliferation, cell viability, expression of Cdc2/Cdk1 and cyclin B in gastric mucosal from patients with H. pylori-positive chronic gastritis (n = 7), MALT (n = 12), or MALT lymphoma (n = 12) were undertaken. Control tissue was obtained from H. pylori- negative patients (n = 5). Proliferating cell nuclear antigen (PCNA), Cdc2, and cyclin B1 were examined in paraffin embedded tissue by immunohistochemistry, while the apoptotic index (AI) was determined using the TUNEL assay. H&E staining for histology and modified Giemsa staining for the detection of H. pylori was conducted simultaneously. When compared to chronic gastritis tissue, those with MALT or MALT lymphoma had an increase in PCNA labeling index of 3.3- and 2.7-fold, while that for Cdc2/Cdk1 increased 2.3- and 3.1-fold, respectively. cyclin B1 labeling was 1.9 and 3.0 fold, while the AI was 3.4- and 1.4-fold higher in MALT and MALT lymphoma tissue, respectively, in the same comparison. On the other hand, the AI index of MALT lymphoma was 2. 5-fold lower than that for MALT tissues. The labeling scores for Cdc2/Cdk1 and cyclin B1 were significantly higher in the germinal center when compared to the mantle and marginal zones of MALT tissues. Using chi(2) and Pearson/Spearman's rho correlation coefficient with regression analyses, there was an inverse correlation between the AI and Cdc2/Cdk1 or cyclin B1 in MALT and MALT lymphoma tissues. There was no correlation between AI and PCNA labeling in any of the tissues. These results suggest that Cdc2/Cdk1 and cyclin B1 expression may be actively associated in the modulation of cellular death by apoptosis, as well as cellular proliferation and transformation during the evolution of H. pylori-associated gastritis to MALT lymphoma. Subclassification of high labeling score (>/=40) for Cdc2/Cdk1 and cyclin B1 and low labeling index (<0.6) for apoptotic cells in H. pylori-associated MALT may help in identifying a population of patients with an increased risk of developing MALT lymphoma.